DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies-Letter

Clin Cancer Res. 2019 Mar 1;25(5):1688. doi: 10.1158/1078-0432.CCR-18-2897.

Authors

Leeyan S Gilmour¹, Penny J Hunt^{2

3}, Karen E Mackenzie¹, Martin de Bock^{4

3}

Affiliations

¹ Department of Paediatric Endocrinology, Christchurch Hospital, Christchurch, New Zealand.
² Department of Endocrinology, Christchurch Hospital, Christchurch, New Zealand.
³ University of Otago, Christchurch, New Zealand.
⁴ Department of Paediatric Endocrinology, Christchurch Hospital, Christchurch, New Zealand. martin.debock@otago.ac.nz.

PMID: 30824629
DOI: 10.1158/1078-0432.CCR-18-2897

No abstract available

Publication types

Letter
Comment

MeSH terms

DEAD-box RNA Helicases*
Humans
Ribonuclease III*

Substances

DICER1 protein, human
Ribonuclease III
DEAD-box RNA Helicases